Editors’ Note
Journal of Cerebral Blood Flow & Metabolism 2017, Vol. 37(7) 2644 ! Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0271678X17705310 journals.sagepub.com/home/jcbfm
Kittani B R, et al. Inhibition of integrin a5b1 with ATN-161 is profoundly neuroprotective following both transient and permanent middle cerebral artery occlusion in experimental ischaemic stroke. Journal Cereb Blood Flow Metab 2017; 37: 1S. DOI: 10.1177/0271678X17695982. The Journal Editors and SAGE have been contacted regarding the possibility of scientific errors in relation to this abstract. Due to publication schedule constraints, it was not possible to withdraw the abstract ahead of publication.
Journal of Cerebral Blood Flow & Metabolism 2017, Vol. 37(7) 2644 ! Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0271678X17705310 journals.sagepub.com/home/jcbfm
Kittani B R, et al. Inhibition of integrin a5b1 with ATN-161 is profoundly neuroprotective following both transient and permanent middle cerebral artery occlusion in experimental ischaemic stroke. Journal Cereb Blood Flow Metab 2017; 37: 1S. DOI: 10.1177/0271678X17695982. The Journal Editors and SAGE have been contacted regarding the possibility of scientific errors in relation to this abstract. Due to publication schedule constraints, it was not possible to withdraw the abstract ahead of publication.
